Serving leading biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: October 20, 2017
| Tradenames: | 1 |
| Patents: | 61 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Mechanism of Action | CTLA-4-directed Antibody Interactions |
| Physiological Effect | Increased T Lymphocyte Activation |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Inventors | Patent Expiration | Status | Orphan | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | Novartis AG (Basel, CH) DANA-FARBER CANCER INSTITUTE, INC. (Boston, MA) Children\'s Medical Center Corporation (Boston, MA) | Sabatos-Peyton; Catherine Anne (Cambridge, MA), Brannetti; Barbara (Basel, CH), Harris; Alan S. (Cambridge, MA), Huber; Thomas (Basel, CH), Pietzonka; Thomas (Basel, CH), Mataraza; Jennifer Marie (Cambridge, MA), Blattler; Walter A. (Brookline, MA), Hicklin; Daniel J. (Montclair, NJ), Vasquez; Maximiliano (Palo Alto, CA), DeKruyff; Rosemarie H. (Portola Valley, CA), Umetsu; Dale T. (Portola Valley, CA), Freeman; Gordon James (Brookline, MA), Hu; Tiancen (Cambridge, MA), Taraszka; John A. (Cambridge, MA), Xu; Fangmin (Cambridge, MA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | Flexus Biosciences, Inc. (Princeton, NJ) | Beck; Hilary Plake (Emerald Hills, CA), Jaen; Juan Carlos (Burlingame, CA), Osipov; Maksim (Belmont, CA), Powers; Jay Patrick (Pacifica, CA), Reilly; Maureen Kay (Belmont, CA), Shunatona; Hunter Paul (San Francisco, CA), Walker; James Ross (Menlo Park, CA), Zibinsky; Mikhail (Lodi, CA), Balog; James Aaron (Lambertville, NJ), Williams; David K. (Delran, NJ), Markwalder; Jay A. (Lahaska, PA), Seitz; Steven P. (Swarthmore, PA), Cherney; Emily Charlotte (Newtown, PA), Zhang; Liping (East Windsor, NJ), Shan; Weifang (Princeton, NJ), Guo; Weiwei (Lawrenceville, NJ), Huang; Audris (New Hope, PA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) | Xi; Ning (Newbury Park, CA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | GENMAB A/S (Copenhagen, DK) | Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) | Brinker; C. Jeffrey (Albuquerque, NM), Carnes; Eric C. (Albuquerque, NM), Ashley; Carlee Erin (Albuquerque, NM), Willman; Cheryl L. (Albuquerque, NM) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | Zymeworks Inc. (Vancouver, CA) | Spreter Von Kreudenstein; Thomas (Vancouver, CA), Dixit; Surjit Bhimarao (Richmond, CA), Escobar-Cabrera; Eric (Burnaby, CA), Lario; Paula Irene (Vancouver, CA), Poon; David Kai Yuen (Richmond, CA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) | Xi; Ning (Newbury Park, CA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | President and Fellows of Harvard College (Cambridge, MA) | King; Randall (Newton, MA), Zeng; Xing (Brookline, MA), Sackton; Katharine L. (Somerville, MA) | ► Subscribe | RX | search | |||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | Kovesdi; Imre (Rockville, MD), Bakacs; Tibor (Budapest, HU), Szabo; Miklos (God, HU) | ► Subscribe | RX | search | ||||
Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | ► Subscribe | University of Virginia Patent Foundation (Charlottesville, VA) The University of Birmingham (Birmingham, GB) | Hunt; Donald F. (Charlottesville, VA), Shabanowitz; Jeffrey (Charlottesville, VA), Malaker; Stacy A. (Charlottesville, VA), Engelhard; Victor H. (Crozet, VA), Zarling; Angela (Richmond, VA), Cummings; Kara L. (Charlottesville, VA), Obeng; Rebecca C. (Charlottesville, VA), Cobbold; Mark (Birmingham, GB) | ► Subscribe | RX | search | |||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,951 others who get our Drug Patent Expiration Alerts:
